Relay Therapeutics Inks Up To $270M Drug Discovery Co. Buy
Cancer-focused biotechnology company Relay Therapeutics Inc. plans to acquire drug discovery company ZebiAI for up to $270 million, in a deal Relay said could help speed up its efforts to use...To view the full article, register now.
Already a subscriber? Click here to view full article